glp-1 bone loss Study reveals exercise and RA combination preserves health during weight Weight loss induced bone loss:

Longato E, Di Camillo B, Sparacino G, Tramontan L, Avogaro A, Fadini GP

Managing constipation Why it happens: GLP-1 medications slow digestion, sometimes leading to constipation, especially if food and water intake decrease

Key risks include: Delayed appropriate treatment : Patients with type 2 diabetes or obesity may postpone evidence-based interventions while using ineffective patches, potentially worsening metabolic control and increasing cardiovascular risk Undisclosed ingredients : While supplement manufacturers must follow current Good Manufacturing Practices, quality control varies widely

"We wanted a partner that had the capacity to supply us with medications and not have an interrupted supply chain

Food & Drug Administration, FDA Approves New Medication for Chronic Weight Management (2023)

Clinical studies suggest that GLP 1 & GIP therapy may be even more effective than GLP 1 alone, with patients often experiencing greater weight loss in a shorter period